Joel R.L. Ehrenkranz
Physician at North Ctr St, Salt Lake City, UT

2011007, Mar 24, 2011

Sep 9, 2010

12/878514

Joel R.L. Ehrenkranz - Salt Lake City UT, US
Thomas S. Scanlan - Portland OR, US

T*AMINE, LLC. - Salt Lake City UT

A61K 9/127, A61K 31/198, A61K 9/133, A61P 3/06, A61P 9/00, A61P 25/00, A61P 9/10, A61P 19/02, A61P 25/30

424450, 514567, 424490

Food or beverage compositions fortified with thyronines and/or thyronamines, processes for increasing T2, T1AM, and/or T0AM in a subject by administering a food or beverage composition that is fortified with at least one thyronine and/or thyronamine compound, and processes for promoting a healthy state by administering a food or beverage composition to a subject that is fortified with at least one thyronine and/or thyronamine compound. Increased levels of T2, T1AM, and/or T0AM in a subject can be associated with at least one of healthy cholesterol levels, healthy triglyceride levels, healthy blood sugar levels, cardiovascular health, healthy sleep patterns, healthy mood, healthy skin, healthy nails, or healthy endocrine function and/or a number of other markers of associated with general health and well-being.

2012006, Mar 15, 2012

Sep 8, 2011

13/228239

Joel R.L. Ehrenkranz - Salt Lake City UT, US
Thomas S. Scanlan - Portland OR, US

T*AMINE, LLC - Salt Lake City UT

A61K 31/195, A61P 3/06

514567

Compositions containing 3,5-L-T2 ((2S)-2-amino-3-[4-(4-hydroxyphenoxy)-3,5-diiodophenyl]propanoic acid) and methods for use thereof. Among other functions presented herein, 3,5-L-T2 can lower cholesterol via a mechanism that is independent of LDL receptor function. Disclosed compositions may include one or more additional active agents, such as, but not limited to, thyroid hormones other than 3,5-L-T2, cholesterol lowering agents, anti-diabetes agents, anti-hypertensives, vasodilators, inotropic agents, anti-coagulants, anti-anginals, anti-arrhythmics, leptin, leptin analogues, and adipokines, a vitamin and mineral composition. Disclosed methods include, but are not limited to, methods for treating hypercholesterolemia in a subject, and methods for treating at least one of metabolic syndrome, hypothyroidism, or thyroid suppression.

2006018, Aug 24, 2006

Jan 20, 2006

11/336629

Joel Ehrenkranz - Salt Lake City UT, US

A61K 38/28, A61K 31/7048

514003000, 514027000

Compositions are disclosed which contain therapeutically effective amounts of phlorizin extract for effecting modification of blood glucose and insulin, for facilitating weight loss, preventing weight gain and for providing beneficial effects in the aging process. Methods of treating animals with phlorizin extract compositions to treat the aforementioned conditions of the body are also disclosed.

2013015, Jun 20, 2013

Dec 7, 2012

13/708576

Joel Ehrenkranz - Salt Lake City UT, US

G09B 19/00

434127, 2064591

The invention provides a system for monitoring food consumption of a subject, comprising: a registration system configured to receive food data comprising nutrients and/or calories contained in one or more food item served to the subject; an intake detection system configured to detect consumption of said one or more food item, thereby generating real-time food consumption data; and a tracking and analysis system configured to receive food data from said registration system and consumption data from said intake detection system, and configured to utilize said food data and said consumption data to calculate a total amount of one or more nutrient and/or calories consumed by the subject. The invention further provides methods for monitoring food consumption of a subject.

2013024, Sep 19, 2013

Sep 12, 2012

13/612293

Joel R.L. Ehrenkranz - Salt Lake City UT, US
Pamela J. Turbeville - Scottsdale AZ, US
David J. You - Tucson AZ, US

G01N 21/49

436501, 422554, 422 70

A device and method for performing a point of care diagnostic test for detecting and quantifying at least one analyte in a biological sample (e.g., a body fluid). A device may include an immunoassay apparatus and a holder with an adjustable variable angle stage for positioning the immunoassay apparatus relative to a light source and a detector device so as to optimize the angle of incidence and angle of radiation to optimize an elastic light scattering signal from the immunoassay apparatus. The elastic light scattering signal may be used to quantify the amount of the analyte(s) of interest present in the sample. The device is based upon elastic light scattering, so the variation in the angle of incidence and angle of reflection are optimized to maximize signal generation due to elastic light scattering.

2007021, Sep 20, 2007

Mar 16, 2007

11/687566

Joel Ehrenkranz - Salt Lake City UT, US
Nathalie Chevreau - Salt Lake City UT, US
Cade Walker - Salt Lake City UT, US

Western Holdings, LLC - Casper WY

A61K 33/24

424439, 424617, 514167, 514 2, 514 23

A composition of matter includes an effective amount of strontium carbonate for affecting bone metabolism. The composition is substantially free of calcium to avoid absorption competition in the digestive tract. The composition is also preferably substantially free of chelating agents, phosphate, phytic acid, oxalates, insoluble fibers, and non-strontium divalent cations or other materials that compete with strontium ions for absorption in the human digestive tract. Other ingredients are optionally added to increase strontium absorption or for their independent positive effective on bone health, including for example vitamin D and vitamin K, quercetin dihydrate, and hesperidin. The composition is preferably administered as a chewable food by blending with a chewable food matrix to form a palatable food that is readily consumed.

2008009, Apr 24, 2008

Apr 20, 2007

11/738331

Joel Ehrenkranz - Salt Lake City UT, US

A61K 31/70, A61P 19/10, A61P 25/00, A61P 3/04, A61P 3/10

514025000

The present invention concerns the isolation of phlorizin from plants of the genus , phlorizin-containing compositions and their uses.